Swain S. 2-hour 75 gm OGTT for screening and Rescreening at 32-34 weeks for diagnosing gestational diabetes-evaluation of maternal and neonatal outcomes. Int J Reprod Contracept Obstet Gynecol [Internet]. 2017 Jun. 24 [cited 2025 Oct. 7];6(7):2926-32. Available from: https://www.ijrcog.org/index.php/ijrcog/article/view/2808